Production (Stage)
Palvella Therapeutics, Inc.
PVLA
$25.40
$1.918.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 928.93% | 1,037.44% | -- | -- | -54.21% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 1,059.60% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | 1,068.97% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -- | 1,068.97% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | 1,068.97% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | 389.96% | -- | -- | -- |
| Total Accrued Expenses | -- | 241.43% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 1,773.96% | -- | -- | -- |
| Total Other Current Liabilities | -- | 1,773.96% | -- | -- | -- |
| Total Current Liabilities | -- | 410.08% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -- | 410.08% | -- | -- | -- |
| Long-Term Debt | -- | 48.27% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 62.43% | -- | -- | -- |
| Total Liabilities | -- | 124.25% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | -- | 8,499.50% | -- | -- | -- |
| Retained Earnings | -- | -22.85% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 174.62% | 184.06% | -- | -- | 20.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 174.62% | 184.06% | -- | -- | 20.57% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,532.40% | 1,713.58% | -- | -- | 83.26% |
|
|
|||||